| Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas Q Deng, G Han, N Puebla-Osorio, MCJ Ma, P Strati, B Chasen, E Dai, ... Nature medicine 26 (12), 1878-1887, 2020 | 396 | 2020 |
| OTUD7B controls non-canonical NF-κB activation through deubiquitination of TRAF3 H Hu, GC Brittain, JH Chang, N Puebla-Osorio, J Jin, A Zal, Y Xiao, ... Nature 494 (7437), 371-374, 2013 | 208 | 2013 |
| Early embryonic lethality due to targeted inactivation of DNA ligase III N Puebla-Osorio, DB Lacey, FW Alt, C Zhu Molecular and cellular biology, 2006 | 140 | 2006 |
| DNA damage-induced cellular senescence is sufficient to suppress tumorigenesis: a mouse model T Van Nguyen, N Puebla-Osorio, H Pang, ME Dujka, C Zhu The Journal of Experimental Medicine 204 (6), 1453-1461, 2007 | 86 | 2007 |
| TRAF3 regulates the effector function of regulatory T cells and humoral immune responses JH Chang, H Hu, J Jin, N Puebla-Osorio, Y Xiao, BE Gilbert, R Brink, ... Journal of experimental medicine 211 (1), 137-151, 2014 | 83 | 2014 |
| Absence of p53-dependent apoptosis leads to UV radiation hypersensitivity, enhanced immunosuppression and cellular senescence O Tavana, CL Benjamin, N Puebla-Osorio, M Sang, SE Ullrich, ... Cell cycle 9 (16), 3348-3356, 2010 | 74 | 2010 |
| Absence of p53-dependent apoptosis combined with nonhomologous end-joining deficiency leads to a severe diabetic phenotype in mice O Tavana, N Puebla-Osorio, M Sang, C Zhu Diabetes 59 (1), 135-142, 2010 | 66 | 2010 |
| Exploring the drug repurposing versatility of valproic acid as a multifunctional regulator of innate and adaptive immune cells R Soria-Castro, A Schcolnik-Cabrera, G Rodríguez-López, ... Journal of immunology research 2019 (1), 9678098, 2019 | 64 | 2019 |
| Fibronectin Binding to the Salmonella enterica Serotype Typhimurium ShdA Autotransporter Protein Is Inhibited by a Monoclonal Antibody Recognizing the A3 … RA Kingsley, D Abi Ghanem, N Puebla-Osorio, AM Keestra, L Berghman, ... Journal of bacteriology 186 (15), 4931-4939, 2004 | 56 | 2004 |
| Use of multi-site radiation therapy for systemic disease control RR Patel, V Verma, HB Barsoumian, MS Ning, SG Chun, C Tang, ... International Journal of Radiation Oncology* Biology* Physics 109 (2), 352-364, 2021 | 43 | 2021 |
| Hiporfin‐mediated photodynamic therapy in preclinical treatment of osteosarcoma M Sun, C Zhou, H Zeng, N Puebla‐Osorio, E Damiani, J Chen, H Wang, ... Photochemistry and photobiology 91 (3), 533-544, 2015 | 42 | 2015 |
| ATM and p53 are essential in the cell-cycle containment of DNA breaks during V (D) J recombination in vivo ME Dujka, N Puebla-Osorio, O Tavana, M Sang, C Zhu Oncogene 29 (7), 957-965, 2010 | 41 | 2010 |
| Detection of infiltrating mast cells using a modified toluidine blue staining N Puebla-Osorio, SNE Sarchio, SE Ullrich, SN Byrne Fibrosis: Methods and Protocols, 213-222, 2017 | 34 | 2017 |
| FSH-and LH-cells originate as separate cell populations and at different embryonic stages in the chicken embryo N Puebla-Osorio, JA Proudman, AE Compton, KE Clements, E Decuypere, ... General and comparative endocrinology 127 (3), 242-248, 2002 | 32 | 2002 |
| DNA damage and repair during lymphoid development: antigen receptor diversity, genomic integrity and lymphomagenesis N Puebla-Osorio, C Zhu Immunologic research 41, 103-122, 2008 | 30 | 2008 |
| Mycobacterium tuberculosis Catalase Inhibits the Formation of Mast Cell Extracellular Traps M Campillo-Navarro, K Leyva-Paredes, L Donis-Maturano, ... Frontiers in immunology 9, 1161, 2018 | 28 | 2018 |
| Early survival prediction framework in CD19-specific CAR-T cell immunotherapy using a quantitative systems pharmacology model A Mueller-Schoell, N Puebla-Osorio, R Michelet, MR Green, A Künkele, ... Cancers 13 (11), 2782, 2021 | 27 | 2021 |
| High plus low dose radiation strategy in combination with TIGIT and PD1 blockade to promote systemic antitumor responses HB Barsoumian, D Sezen, H Menon, AI Younes, Y Hu, K He, ... Cancers 14 (1), 221, 2022 | 26 | 2022 |
| Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activity AI Younes, HB Barsoumian, D Sezen, V Verma, R Patel, M Wasley, Y Hu, ... Translational Oncology 14 (2), 100983, 2021 | 24 | 2021 |
| Platelet-activating factor induces cell cycle arrest and disrupts the DNA damage response in mast cells N Puebla-Osorio, E Damiani, L Bover, SE Ullrich Cell Death & Disease 6 (5), e1745-e1745, 2015 | 22 | 2015 |
